CRMD Q1 2022 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7,636-91.3% YoY

Gross Profit

$6,10980.0% margin

Operating Income

-$7M-92094.8% margin

Net Income

-$7M-92142.8% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

-86.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$65M

Total Liabilities

$5M

Stockholders' Equity

$60M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7,636	$88,261	-91.3%
Gross Profit	$6,109	$26,922	-77.3%
Operating Income	-$7M	-$7M	+2.5%
Net Income	-$7M	-$7M	+2.5%